Literature DB >> 20452853

Abstracting stage in population-based cancer registries: the example of oral cavity and oropharynx cancers.

Marianna de Camargo Cancela1, François Chapuis, Maria Paula Curado.   

Abstract

Population-based cancer registries (PBCRs) are instruments to provide cancer incidence to promote cancer control and etiological research. A setting of mandatory (standard) variables is routinely collected for patient and tumor. One recommended variable is tumor stage, which supplies information on disease status and is an essential prognostic factor. However, it is not considered as necessary information to be collected by the PBCR. There are studies showing the value of stage as a prognostic variable to evaluate survival, socio-economic status, race and ethnics differences. Our aim is to analyze the feasibility of PBCRs in abstracting TNM for oral cavity and oropharynx. These topographies were selected due to the clinical accessibility of stage tumors by visual inspection and palpation. About 23% of the PBCRs who contributed to CI5-IX indicated their collection of TNM stage for all cancer sites. We analyzed 23,935 cases of oral cavity (OCC) and oropharynx cancer (OPC) from 13 PBCRs. Complete TNM stage for OCC was 52.7% for males and 47.6% for females; for OPC, it was 56% in both genders. Incomplete stage on OCC and OPC ranged from 22 to 25%. Missing was about 18-27% (most common in oral cavity). Missing stage was significantly higher in males for OCC aged > or =70 years, OR 1,64 (1.39-1.94). Our results demonstrate that OPC tend to have more stage, when compared with OCC. Even if it can be diagnosed by visual inspection, these results highlight the fact that information on stage can be a reliable indicator of access to healthcare and diagnosis awareness. Our results demonstrate that is feasible for PBCR to collect stage, although improving completeness of this information needs further technical training and international recommendation to adopt TNM stage as a standard variable for the PBCRs.

Entities:  

Mesh:

Year:  2010        PMID: 20452853     DOI: 10.1016/j.canep.2010.04.012

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  7 in total

1.  Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany.

Authors:  Katrin Hertrampf; Jörg Wiltfang; Alexander Katalinic; Olaf Timm; Hans-Jürgen Wenz
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-14       Impact factor: 4.553

2.  Diagnosis and management of head and neck cancers in a high-incidence area in France: A population-based study.

Authors:  Anne-Valerie N Guizard; Olivier J Dejardin; Ludivine C Launay; Simona Bara; Bénédicte M Lapôtre-Ledoux; Emmanuel B Babin; Guy D Launoy; Karine A Ligier
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  Oral cancer awareness campaign in Northern Germany: first positive trends in incidence and tumour stages.

Authors:  Katrin Hertrampf; Ron Pritzkuleit; Eva Baumann; Jörg Wiltfang; Hans-Jürgen Wenz; Annika Waldmann
Journal:  J Cancer Res Clin Oncol       Date:  2020-07-02       Impact factor: 4.553

4.  Survival of patients with oral cavity cancer in Germany.

Authors:  Stefan Listl; Lina Jansen; Albrecht Stenzinger; Kolja Freier; Katharina Emrich; Bernd Holleczek; Alexander Katalinic; Adam Gondos; Hermann Brenner
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

5.  Quality of cancer registry data: completeness of TNM staging and potential implications.

Authors:  Mette Søgaard; Morten Olsen
Journal:  Clin Epidemiol       Date:  2012       Impact factor: 4.790

6.  Completeness of T, N, M and stage grouping for all cancers in the Mallorca Cancer Registry.

Authors:  M Ramos; P Franch; M Zaforteza; J Artero; M Durán
Journal:  BMC Cancer       Date:  2015-11-04       Impact factor: 4.430

7.  Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013.

Authors:  Chiara Di Girolamo; Sarah Walters; Sara Benitez Majano; Bernard Rachet; Michel P Coleman; Edmund Njeru Njagi; Melanie Morris
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.